Xcout Intel
Adaptive Biotechnologies Corp. competitors & alternatives
The 12 closest competitors and alternatives to Adaptive Biotechnologies Corp. among biotechnology companies — ranked by similarity to what Adaptive Biotechnologies Corp. actually does, not by market-cap band.
Subscribe to see Adaptive Biotechnologies Corp.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Adaptive Biotechnologies Corp.
Adaptive Biotechnologies Corp. is a biotechnology company headquartered in Seattle, Washington, United States. The firm focuses on decoding and analyzing the human immune system to address various diseases.
Adaptive Biotechnologies Corp. at a glance
Adaptive Biotechnologies Corp. is a biotechnology company headquartered in Seattle, United States. It is publicly listed (ADPT) with a market capitalisation of $4.2B. Xcout tracks 22 named people at Adaptive Biotechnologies Corp., including Chad Robins (Chief Executive Officer, Co-founder, Chairman of the Board). Xcout recorded 38 job postings from Adaptive Biotechnologies Corp. in the last 90 days, naming tools such as Salesforce, ServiceNow, Workday.
Adaptive Biotechnologies Corp. leadership
- Chad RobinsChief Executive Officer, Co-founder, Chairman of the Board
- Julie RubinsteinPresident & Chief Operating Officer
- Kyle PiskelVice President, Chief Financial Officer & Principal Accounting Officer
- Sharon BenzenoChief Commercial Officer of Immune Medicine
- Susan BobulskyChief Commercial Officer of MRD
- Clarice McCauleyHead of Legal, Corporate Secretary, VP & Chief Compliance Officer
16 more named people on record for Adaptive Biotechnologies Corp., with roles, board committees and tenure — see the full roster →
Adaptive Biotechnologies Corp. funding rounds on record
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $195.1M | — |
Some filings are not shown as funding rounds.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Adaptive Biotechnologies Corp.
Xcout recorded 38 job postings from Adaptive Biotechnologies Corp. in the last 90 days, from a hiring record Xcout has kept since June 2026.
Tools named in Adaptive Biotechnologies Corp.'s job postings
The weekly hiring trend, the roles and locations behind it — see Adaptive Biotechnologies Corp.'s hiring signals →
Top 12 Adaptive Biotechnologies Corp. competitors
Ranked by semantic similarity — how close each company is to Adaptive Biotechnologies Corp. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Resolution Bioscience is a precision medicine company specializing in cancer diagnostics, DNA sequencing, and liquid biopsy, located in Bellevue, Washington.
Similar biotechnology company
Impact Proteomics provides a proprietary antigen profiling and protein identification platform that analyzes patient samples to map disease-associated antigens without cloned intermediates. The company serves biotechnology and diagnostic partners by enabling target discovery, companion diagnostics development, and therapeutic selection for oncology and autoimmune diseases.
Similar biotechnology company
SomaLogic, Inc. is an active biotechnology company headquartered in Boulder, Colorado, specializing in proteomics technology and biomarker discovery.
Biotech
Cofactor Genomics develops RNA-Seq technology and predictive diagnostics to help match cancer patients with appropriate immunotherapy treatments. The company offers tools such as the OncoPrism assay and collaborates with healthcare systems and clinical researchers to evaluate multidimensional biomarkers for various solid tumor cancers.
Biotech
Precede Biosciences is a biotechnology company developing blood-based liquid-biopsy technologies for molecular profiling of cancer. Its tests are intended to support oncology research, precision treatment decisions, and pharmaceutical drug-development programs.
Biotech
Epigenomics AG is a molecular diagnostics company headquartered in Germany. The company also has a wholly owned subsidiary, Epigenomics Inc., based in Seattle, Washington, USA.
Similar biotechnology company
Countable Corp. (operating as Countable Labs) develops and manufactures instruments, assays, and platforms for high-precision PCR DNA and RNA detection. Serving researchers, clinical laboratories, and life sciences organizations, the company provides tools for rare event detection, cell and gene therapy, and molecular diagnostics.
Biotech
IMU Biosciences is headquartered in London, United Kingdom, and operates in the biotechnology sector. The company develops data platforms and immunological profiling technologies supported by a growing scientific team.
Similar biotechnology company
Harmonigenic Corp. is a diagnostics and biotechnology company headquartered in Rochester, New York. The company brings radical innovation to personalized precision medicine, focusing on initial diagnostic and treatment decisions.
Similar biotechnology company
Intus Biosciences develops proprietary microbiome analysis technology that combines patented science, long-read sequencing, and AI to deliver strain-level resolution of microbial data. The company serves healthcare providers, researchers, and consumers through clinical-grade profiling products like GutID and research partnerships aimed at drug development and biomarker discovery.
Biotech
Exact Sciences Corporation is an American molecular diagnostics company based in Madison, Wisconsin, specializing in the detection of early-stage cancers. The company provides products for the detection and prevention of colorectal cancer, including Cologuard, the first stool DNA test for colorectal cancer, along with additional screening and precision oncological tests for other types of cancer.
Biotech
Illumina, Inc. specializes in delivering advanced sequencing and array technologies designed for genetic and genomic examination. These offerings cater to a diverse array of markets, fostering the widespread use of genomic insights across both research laboratories and clinical environments. Key application areas include life sciences, cancer diagnostics, reproductive medicine, agricultural science, and various nascent fields. The company's portfolio encompasses specialized instrumentation and associated consumables vital for genetic analysis. Additionally, it offers comprehensive genotyping and sequencing services, extends instrument maintenance contracts, and engages in development and licensing partnerships, alongside providing cancer screening services. Illumina's client base is extensive, comprising genomic research facilities, universities, state-funded laboratories, and healthcare providers. It also serves pharmaceutical firms, biotechnology companies, commercial molecular diagnostics providers, and businesses focused on consumer genomics. Globally, Illumina distributes its products through direct sales channels in North America, Europe, Latin America, and the Asia-Pacific. Furthermore, it leverages third-party life-science distributors to reach markets across Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Adaptive Biotechnologies Corp. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Adaptive Biotechnologies Corp.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →